TB006: A Real Hope Against Alzheimer’s and Dementias

TB006Reviews.org was created by The BeEx Foundation as a public resource to share information, support, and real patient experiences. TB006 is not a cure. It is an investigational treatment available through the FDA’s Expanded Access Program. Some patients have reported improvements in quality of life, though individual results vary.

The Science

What makes TB006 different than others in the market?

TB006 is an investigational treatment targeting Galectin-3, a protein associated with brain inflammation. Some patients in the Expanded Access Program have reported improvements in cognitive symptoms, though results vary.

Learn More

Why Share?

Your story could help others find hope.

We need your voice. Every experience helps patients and families facing Alzheimer’s understand the possibilities of TB006. Sharing is simple and meaningful.

Share Your Story

Testimonials

Real Experiences. Real People.

The following are individual patient experiences reported under the FDA’s Expanded Access Program. TB006 is an investigational drug and has not been approved by the FDA. These results are not typical and may not reflect your experience. Individual outcomes vary.

After just a few treatments with TB006, I felt like myself again. My family noticed a difference before I did — I was speaking more clearly, staying emotionally present, and even getting more done around the house. It helped me reconnect with my loved ones and regain my motivation. When I stopped treatment, I could feel the change — and I knew I had to return.

Small Business Owner Diagnosed with Lewy Body dementia

After starting treatment with TB006, I found myself becoming more organized. I began creating to-do lists again and actually getting things done — something I hadn’t done in a long time.

84-year-old Retiree with Memory Loss

Within just two months of starting TB006, I could feel a difference. I’m thinking more clearly, and I’ve even noticed my memory starting to come back.

85-year-old Woman Diagnosed with Alzheimer's Disease

After starting TB006, I felt like I was coming back to life. My memory improved, I began participating in conversations again, and even started cooking and dressing myself like I used to. I could calculate checks and enjoy going out — things I hadn’t done in years.

91-year-old Former CPA with Memory Loss

After my first TB006 treatment, my family saw a change almost immediately. I was more alert, more engaged, and even picked up the TV remote — something I hadn’t done in months. Over time, my memory, energy, and sense of humor returned. I felt like I was truly coming back to life.

94-year-old Retired Teacher Living with Dementia

After starting TB006, everything began to change. My memory improved — I could remember my birthday again. The constant pain eased, and I felt calmer and more energized. I even got dressed up and visited my son after being homebound for two years. I feel more alive, more connected, and more like myself every day.

90-year-old Woman with Dementia and Hypertension

The Core Issues

Dementia is a Thief. We Want to Stop It.

TB006 represents our commitment to supporting patients and families facing Alzheimer’s with access to investigational options under the FDA’s Expanded Access Program.

Memory Loss

Alzheimer's gradually steals cherished memories, starting with recent events and eventually affecting even long-term memories.

Cognitive Function

Beyond memory, Alzheimer's takes away problem-solving abilities, language skills, and the capacity for independent decision-making.

Precious Time

The disease robs patients and families of quality time together, as care needs increase and personalities change.

Disclaimer

Importantly, it is a treatment, not a cure.

We anticipate this website will attract two types of people: Those searching for an answer to the devastating loss of cognition for themselves or their loved ones and those who have had a positive experience with TB006 and want to share their stories with the world.

Many patients will need to continue treatment with TB006 to sustain its positive effects. Hopefully, someday, a cure for dementia will be developed, but until then, dementia patients need a higher quality of life, and the opportunity to thrive once again.

TB006 has not been approved by the U.S. Food and Drug Administration. It is available only through FDA-authorized Expanded Access Programs or clinical trials.